The Medical Device Business Journal — Medical Device News & Articles | MassDevice
More news from the Emerald Isle as the Boston Scientific Corp. (NYSE:BSX) plans to spend $37 million on overseas research and development, this time at its R&D facility in Clonmel, Ireland.
The Natick, Mass.-based company hopes to jump-start development of a next generation cardiac rhythm management system.
Updated 8/8/2011 7:15 p.m.
Osteologix Inc. (OTC:OLGX) decided to pull up stakes in the U.S. and remove its stock from public trading.
In an effort to cut costs, the company plans to deregister its stock on the NASDAQ exchange and close its U.S. office in Glen Allen, Va., in order to consolidate into its Dublin, Ireland-based subsidiary Osteologix Holdings Ltd.
